OVERVIEW:
SIMCO is proud to partner with the Primary Health Care Committee in Kuwait to implement the Diabetic Retinopathy Screening Program, aimed at early detection and prevention of vision loss among diabetic patients. This initiative is a key step towards improving the overall health and well-being of individuals with diabetes by detecting retinopathy in its earliest stages.”
Project SCOPE:
OVERVIEW:
SIMCO is proud to partner with the Primary Health Care Committee in Kuwait to implement the Diabetic Retinopathy Screening Program, aimed at early detection and prevention of vision loss among diabetic patients. This initiative is a key step towards improving the overall health and well-being of individuals with diabetes by detecting retinopathy in its earliest stages.”
Project SCOPE:
Technology & Methodology:
The Diabetic Retinopathy Screening Program utilizes cutting-edge imaging technology, including retinal cameras and AI-based analysis, to detect early signs of diabetic eye disease. The process is non-invasive, quick, and provides accurate results. Trained ophthalmologists analyze the images, and patients are promptly referred for further treatment if necessary.”
SIMCO is proud to partner with the Primary Health Care Committee in Kuwait to implement the Diabetic Retinopathy Screening Program
At SIMCO Health Intelligence, we are proud to be driving the next generation of healthcare innovation across the Middle East and Africa (MEA).
Al Saleh Medical Center in South Khitan, Kuwait, recently hosted an event to unveil its new Open MRI project.